Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209499-05-000107
Filing Date
2005-09-06
Accepted
2005-09-06 17:53:50
Documents
2
Period of Report
2005-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3152
2 EDGAR SUPPORTING DOCUMENT burkhardt2.txt EX-24 3131
  Complete submission text file 0001209499-05-000107.txt   8436
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Issuer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8600 W. BRYN MAWR AVENUE SUITE 500N CHICAGO IL 60631
Business Address 8600 WEST BRYN MAWR AVE., STE. 500N CHICAGO IL 60631 7737148669
BURKHARDT EDWARD A (Reporting) CIK: 0001021314 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-11397 | Film No.: 051071267